Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

REMI-AI Rapid Detection Module (REMI-AI RDM)

K-Number: K240408 · 2024-10-17

ApplicantEpitel, Inc.
Decision Date2024-10-17
Product CodeOMB
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

REMI-AI Rapid Detection Module (REMI-AI RDM) is a medical device manufactured by Epitel, Inc.. It received FDA 510(k) clearance on 2024-10-17 under approval number K240408. The device is classified under product code OMB. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the REMI-AI Rapid Detection Module (REMI-AI RDM)?

REMI-AI Rapid Detection Module (REMI-AI RDM) is a medical device that received FDA 510(k) clearance on 2024-10-17. It is manufactured by Epitel, Inc.. The 510(k) number is K240408.

When was REMI-AI Rapid Detection Module (REMI-AI RDM) approved by the FDA?

REMI-AI Rapid Detection Module (REMI-AI RDM) received FDA 510(k) clearance on 2024-10-17, under approval number K240408.

What company makes REMI-AI Rapid Detection Module (REMI-AI RDM)?

REMI-AI Rapid Detection Module (REMI-AI RDM) is manufactured by Epitel, Inc..

What is the FDA product code for REMI-AI Rapid Detection Module (REMI-AI RDM)?

The FDA product code for REMI-AI Rapid Detection Module (REMI-AI RDM) is OMB.

Related Clinical Trials

Related PubMed Literature

Other Devices by Epitel, Inc.

Related Devices (Code: OMB)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.